Literature DB >> 7942986

Case report: diabetes mellitus as a predisposing factor in the development of pyomyositis.

D S Belsky1, C D Teates, M L Hartman.   

Abstract

Pyomyositis is an uncommon infection in temperate climates, usually resulting from Staphylococcus aureus infection of skeletal muscle. In this report, the authors describe a patient with untreated Type 2 diabetes mellitus who suffered nonpenetrating blunt trauma to his left anterior thigh, and S. aureus pyomyositis and secondary osteomyelitis of his proximal tibia and patella subsequently developed as a result of delayed diagnosis and treatment. Patients with diabetes mellitus are at increased risk for the development of pyomyositis because of more frequent S. aureus colonization of skin, nasal mucosa, and oropharynx; a delay in definitive treatment can lead to significant morbidity in these patients. Computed tomography or magnetic resonance imaging may be helpful in the diagnosis of pyomyositis. An anemia of chronic disease may result from this disorder, which resolves with treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7942986     DOI: 10.1097/00000441-199430840-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

1.  Arm pain and erythema.

Authors:  Brandon M Barth; Andrew L Juergens
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

2.  Pyomyositis in Nodding Syndrome (NS) patient--a case report.

Authors:  David Lagoro Kitara; Amos Deogratius Mwaka; Henry R Wabinga; Paul Okot Bwangamoi
Journal:  Pan Afr Med J       Date:  2013-10-23

3.  High Prevalence of Malnutrition among the Above Thirteen with Primary Pyomyositis in Northern Uganda.

Authors:  David Lagoro Kitara; Paul Okot Bwangamoi; Henry Wabinga; Michael Odida
Journal:  Br J Med Med Res       Date:  2015

4.  The double burden of diabetes and global infection in low and middle-income countries.

Authors:  Susanna Dunachie; Parinya Chamnan
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-02-01       Impact factor: 2.184

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.